Boardroom Alpha
Start trial
8-K primary document
NMTC · Current Report (Form 8-K) · Filed April 3, 2026

Neuroone Medical Technologies Corp — 8-K exhibit

ea028508501ex10-1.htm
Neuroone Medical Technologies Corp on Boardroom Alpha

Exhibit 10.1

 

FIRST AMENDMENT TO

NEUROONE MEDICAL TECHNOLOGIES CORPORATION

2025 EQUITY INCENTIVE PLAN

 

RECITALS

 

A.NeuroOne Medical Technologies Corporation, a Delaware corporation (the “Company”) sponsors the NeuroOne Medical Technologies, Inc. 2025 Equity Incentive Plan (the “Plan”).

 

B.The Plan is amended by this Amendment 1 (this “First Amendment”) in the following respects, effective from and after the date this First Amendment is approved by the stockholders of NeuroOne Medical Technologies Corporation, in accordance with the Plan. Following such effective date, any reference to the “Plan” shall mean the Plan, as amended by this First Amendment. All capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Plan.

 

AMENDMENT

 

1. Section 2(a) of the Plan is hereby deleted in its entirety and replaced with the following:

 

“Share Reserve. Subject to adjustment in accordance with Section 2(c) and any adjustments as necessary to implement any Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed the sum of: (i) 4,500,000 new shares, plus (ii) the number of Returning Shares, if any, as such shares become available from time to time. In addition, subject to any adjustments as necessary to implement any Capitalization Adjustments, such aggregate number of shares of Common Stock will automatically increase on January 1st of each year for a period of five years commencing on January 1, 2027 and ending on (and including) January 1, 2031, by an amount equal to 5% of the Fully Diluted Shares as of the last day of the preceding calendar year; provided, however that the Board may act prior to the effective date of any such annual increase to provide that the increase for such year will be a lesser number of shares of Common Stock.”

 

2. Except as set forth in this amendment, the Plan shall be unaffected hereby and shall remain in full force and effect.

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer